Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioSante shares yo-yo in response to financings

This article was originally published in Scrip

Executive Summary

BioSante Pharmaceuticals proved that shares can go down as well as up as the market responded conversely to two financial transactions. After jumping by 33% from $1.50 on 23 December to close 27 December at $2.00, following the news that it had extended a $25 million committed equity financing facility with Kingsbridge Capital by a year to the end of 2011, the company's stock closed 20% down on 28 December at $1.61 after the firm announced that it would raise $16.9 million net in an after-hours registered direct offering on 27 December.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts